Sagility Share Price: Results Toh Mast, Par Stock Kyu Gira? Margin Tension!

TECH
Whalesbook Logo
AuthorKavya Nair|Published at:
Sagility Share Price: Results Toh Mast, Par Stock Kyu Gira? Margin Tension!
Overview

Sagility ne toh Q4 FY26 results mein dhamaka kar diya hai! Company ka net profit **41.2%** badh kar **₹257.7 crore** ho gaya hai aur revenue bhi **29%** badh kar **₹2,024.2 crore** tak pahunch gaya. Full year revenue bhi **29.1%** growth dikha raha hai. Par itne acche numbers ke baad bhi, stock **4.24%** gir gaya!

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Results Mein Zoom, Stock Mein Drop? 🤔

Yaar, Sagility ne FY26 ke Q4 results mein pakka kamaal kar diya. Net profit 41.2% upar, ₹257.7 crore tak pahunch gaya aur revenue bhi 29% bhaag kar ₹2,024.2 crore ho gaya. Poore saal ki revenue growth bhi 29.1% rahi hai. Company ne naye business bhi jeete hain aur AI solutions bhi update kiye hain. Lekin market ka reaction dekh ke lagta hai investors kuch aur hi dekh rahe hain, kyuki stock 4.24% gir kar ₹43.09 par aa gaya tha 12 May 2026 ko. Lagbhag 2.7 crore shares trade hue.

Toh Stock Gira Kyu? Margin Pressure Aur US Sector Ki Fikar!

Asal tension EBITDA margins mein hai jo revenue badhne ke baad bhi flat rahe, sirf 24% par atke hue hain. Investors is baat ko notice kar rahe hain ki revenue growth 29% thi jabki adjusted EBITDA growth 20.6% thi. Company ke CEO ne bhi bola hai ki US healthcare payers aur providers ke liye environment thoda challenging hai. Aur ek badi chinta ye hai ki 10 May 2026 ko lock-up period khatam hone ke baad 93.6 crore se zyada shares market mein aa sakte hain, jisse selling pressure badh sakta hai. Company par pichle 12 mahine mein ₹6.33 billion ka negative net cash bhi hai.

Brokies Kya Keh Rahe Hain?

Bhale hi stock gir gaya ho, analysts ka confidence abhi bhi high hai. Bahut saare analysts ne 'Strong Buy' rating de rakhi hai aur target price mein 35% tak ka upside dikha rahe hain. Kuch ne toh earnings estimates bhi badha di hain. Par abhi market in analyst calls par dhyan nahi de raha, shayad US healthcare sector ki uncertainty aur margins ka tension zyada hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.